Our top pick for
Banco de Chile is a banks-regional business based in the US. Banco de Chile shares (BCH) are listed on the NYSE and all prices are listed in US Dollars. Banco de Chile employs 13,134 staff and has a market cap (total outstanding shares value) of 0.00.
|Latest market close||$17.19|
|52-week range||$14.66 - $24.88|
|50-day moving average||$18.63|
|200-day moving average||$19.83|
|Wall St. target price||$23.16|
|Dividend yield||$0.005 (0.03%)|
|Earnings per share (TTM)||$1.80|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||4.37%|
|1 month (2021-09-22)||-12.03%|
|3 months (2021-07-22)||-6.93%|
|6 months (2021-04-22)||-27.47%|
|1 year (2020-10-22)||3.00%|
|2 years (2019-10-22)||-37.56%|
|3 years (2018-10-22)||85.88|
|5 years (2016-10-21)||65.4646|
Valuing Banco de Chile stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Banco de Chile's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Banco de Chile's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 9x. In other words, Banco de Chile shares trade at around 9x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Banco de Chile's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.5641. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Banco de Chile's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Gross profit TTM||$1,426.8 billion|
|Return on assets TTM||1.15%|
|Return on equity TTM||14.36%|
|Market capitalisation||$8.3 billion|
TTM: trailing 12 months
There are currently 350,296 Banco de Chile shares held short by investors – that's known as Banco de Chile's "short interest". This figure is 13.6% down from 405,428 last month.
There are a few different ways that this level of interest in shorting Banco de Chile shares can be evaluated.
Banco de Chile's "short interest ratio" (SIR) is the quantity of Banco de Chile shares currently shorted divided by the average quantity of Banco de Chile shares traded daily (recently around 84003.836930456). Banco de Chile's SIR currently stands at 4.17. In other words for every 100,000 Banco de Chile shares traded daily on the market, roughly 4170 shares are currently held short.
However Banco de Chile's short interest can also be evaluated against the total number of Banco de Chile shares, or, against the total number of tradable Banco de Chile shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Banco de Chile's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Banco de Chile shares in existence, roughly 0 shares are currently held short) or 0.002% of the tradable shares (for every 100,000 tradable Banco de Chile shares, roughly 2 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Banco de Chile.
Find out more about how you can short Banco de Chile stock.
Dividend payout ratio: 42.05% of net profits
Recently Banco de Chile has paid out, on average, around 42.05% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.58% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Banco de Chile shareholders could enjoy a 3.58% return on their shares, in the form of dividend payments. In Banco de Chile's case, that would currently equate to about $0.005 per share.
While Banco de Chile's payout ratio might seem fairly standard, it's worth remembering that Banco de Chile may be investing much of the rest of its net profits in future growth.
Banco de Chile's most recent dividend payout was on 8 April 2021. The latest dividend was paid out to all shareholders who bought their shares by 25 March 2021 (the "ex-dividend date").
Banco de Chile's shares were split on a 3:1 basis on 22 November 2018. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Banco de Chile shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for Banco de Chile shares which in turn could have impacted Banco de Chile's share price.
Over the last 12 months, Banco de Chile's shares have ranged in value from as little as $14.6621 up to $24.88. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Banco de Chile's is 0.405. This would suggest that Banco de Chile's shares are less volatile than average (for this exchange).
Banco de Chile, together with its subsidiaries, provides banking and financial products and services to customers in Chile. The company operates through four segments: Retail, Wholesale, Treasury, and Subsidiaries. It offers deposit products, such as checking accounts, current accounts, demand deposits and accounts, saving accounts, and time deposits; commercial, mortgage, consumer, working capital, syndicated, and installment loans; and credit and debit cards. The company also provides leasing, factoring, and foreign trade services; international and treasury banking services; and financial advisory services for mergers and acquisitions, debt restructuring assistance, and payments and collections services. In addition, it offers liquidity management services, debt instruments, and derivative contracts and leases, as well as financial transactions business and currency trading services; and securities brokerage, mutual funds management, wholesale customers, investment banking and management, insurance brokerage, and securitization services. It serves individuals, small and medium-sized companies, corporate clients, and large companies. As of December 31, 2021, the company operated through a network of 334 branches and 1,766 automatic teller machines.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.